<DOC>
	<DOCNO>NCT00376844</DOCNO>
	<brief_summary>RATIONALE : External-beam radiation therapy use high-energy x-ray kill tumor cell . Implant radiation therapy use radioactive material place directly near tumor kill tumor cell . Giving external-beam radiation therapy implant radiation therapy surgery may kill tumor cell remain surgery . Sometimes , surgery , tumor may need treatment progress . In case , observation may sufficient . It yet know whether radiation therapy effective observation give surgery treat stage I endometrial cancer . PURPOSE : This randomized phase III trial study external-beam radiation therapy implant radiation therapy see well work compare observation treat patient undergone surgery stage I endometrial cancer .</brief_summary>
	<brief_title>External-Beam Radiation Therapy Compared With Vaginal Brachytherapy After Surgery Stage I Endometrial Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare rate 5-year locoregional relapse patient undergo external-beam radiotherapy vaginal brachytherapy v observation surgery stage I endometrial cancer . - Compare 5-year rate distant metastases patient . - Determine overall survival rate patient . - Determine prognostic factor relapse morbidity . OUTLINE : This randomize , multicenter study . Patients randomize 1 2 treatment arm . - Arm I : Patients undergo either vaginal brachytherapy external-beam radiotherapy . - Arm II : Patients observe undergo treatment . After completion study treatment , patient follow approximately 83 day . PROJECTED ACCRUAL : A total 400 patient accrue study .</detailed_description>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis stage I endometrial cancer meet 1 follow criterion : Grade 1 2 deep ( â‰¥ 50 % ) myometrial invasion ( stage IC ) Grade 2 3 superficial ( &lt; 50 % ) myometrial invasion ( stage IB ) No grade 3 endometrial carcinoma deep myometrial invasion Total abdominal hysterectomy bilateral salpingooophorectomy require prior randomization PATIENT CHARACTERISTICS : Menopausal status specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>stage I endometrial carcinoma</keyword>
</DOC>